Botanical illustration of goldenseal.

Goldenseal Supplements: Benefits, Berberine and Medicine Interactions

What is goldenseal?

Goldenseal, Hydrastis canadensis, is a North American plant with a yellow rhizome, or underground stem, and roots used in herbal preparations. It is also called yellow root or orangeroot. Supplements contain dried plant material or extracts and are marketed for respiratory infections, digestion and “immune support.” Its plant compounds include berberine, hydrastine and canadine, collectively described on labels as alkaloids.

Its medicine interactions are better demonstrated than its ability to improve those advertised health conditions. The preparation matters: a root capsule, a liquid extract and isolated berberine are different products.

How was goldenseal used historically?

Goldenseal’s medicinal history includes several distinct practices. NCCIH documents Indigenous North American use[1] for digestive disorders, wounds, and skin and eye conditions.

A US Forest Service historical review[2] gives more specific attributions: Cherokee uses included washes for inflammation and remedies for indigestion, poor appetite and weakness; Iroquois uses included root remedies for whooping cough, pneumonia and digestive complaints. It also records facial staining and clothing dyes. These accounts document use, rather than effectiveness.

An early USDA historical account, reproduced in Harding’s Ginseng and Other Medicinal Plants[3], describes the root as medicine and its yellow juice as a dye. It cites Barton’s 1804 account of an alcoholic root infusion used as a bitter tonic in western Pennsylvania and a cold-water infusion used externally as an eye wash. The book quotes an earlier account; these descriptions are not present-day instructions for making an eye preparation.

The account describes growing demand among herbal practitioners in the mid-19th century, helping turn a regional plant into a commercial medicine.

The Eclectic tradition was also more specific than a general remedy for severe inflammation. Felter’s 1922 text[4] described preparations for nose and throat complaints, digestive problems and some urinary conditions. He generally favored subacute or chronic conditions with mucus discharge and warned against use when the stomach or intestines were acutely inflamed. This records the practitioners’ reasoning, rather than validating those treatments today.

The digestive tradition persists in Health Canada’s oral monograph[5], which lists traditional uses for digestive upset, as a bitter to aid digestion and appetite, and as a mild laxative. It also includes traditional digestive inflammatory or infectious conditions such as gastritis. These are traditional-use claims, rather than clinical-trial findings.

Why do people take goldenseal?

Claimed benefit Dose / form studied Research verdict Evidence strength
Help colds or respiratory infections No established effective goldenseal preparation NIH[1] finds inadequate rigorous clinical evidence. Insufficient
Improve diarrhea or other digestive conditions No established effective dose Traditional use has not supplied a dependable clinical result. Insufficient
Provide berberine's metabolic effects Goldenseal products contain variable alkaloids Isolated-berberine findings cannot simply be assigned to the whole herb. Insufficient

Common dosage

There is no established goldenseal dose for treating a cold or digestive infection. Health Canada’s oral monograph[5] lists 0.6–3 g of dried root and rhizome per day for adults under traditional Herbal Medicine uses. That is a traditional-use labeling basis, not a dose proven effective in a clinical trial.

The monograph covers powdered material and several non-standardized preparations, including tinctures and fluid extracts. Their amounts are expressed as dried-plant equivalents. A tincture’s milliliters depend on its concentration; an extract’s milligrams cannot simply be read as milligrams of whole root.

Form What the amount tells you What it does not establish
Dried root/rhizome powder Mass of the dried plant material A fixed berberine or hydrastine dose
Dry extract Mass of the extract; the extraction ratio and any measured alkaloids add context Equivalence to the same mass of root, or a clinically effective “high-potency” serving
Tincture or fluid extract Volume plus concentration or dried-root equivalent A universal drop count or superior absorption

The human studies below used particular products and short courses. They tested medicine interactions, so their amounts should not be treated as recommended treatment doses.

Is goldenseal equivalent to berberine?

No. Goldenseal contains a mixture of alkaloids. An isolated berberine supplement provides a stated amount of that constituent; the same milligram amount of goldenseal root does not.

NCCIH[1] notes that little berberine may be absorbed when goldenseal is taken orally. That limits the transfer of berberine trial results to the herb.

The distinction also matters for interactions: goldenseal contains other constituents, and its effects on medicines cannot be predicted from berberine alone.

What should the label tell you?

Look for Hydrastis canadensis, the plant part, actual daily amount and whether the product is dried root/rhizome or an extract. For an extract, look for any stated alkaloid amounts and how much dried plant material was used to make the extract. “Total alkaloids” is not the same measurement as berberine alone. An isolated berberine ingredient should be identified separately.

Authentication matters: NCCIH reports[1] that some products have contained other herbs or unlisted ingredients alongside or instead of goldenseal. Yellow color does not establish plant identity. A blend should also state how much goldenseal it supplies; the presence of echinacea does not establish that the combination works better.

What does the interaction research show?

Goldenseal can change medicine exposure—the amount reaching the bloodstream over time. Human studies show that the direction and size depend on the medicine, its dose and the goldenseal product.

Medicine or test What happened with the studied goldenseal product How to read it
Metformin, 50 mg test dose in 16 healthy adults Total exposure was about 23% lower. A small test dose is not a prediction for usual diabetes doses.
Metformin, usual prescribed doses in 22 adults with type 2 diabetes Average total exposure was about 7% lower, within the study's predefined no-effect range; smaller dose subgroups differed. The later study narrows the earlier warning; it does not erase it.
Midazolam, 2.5 mg enzyme probe in 16 healthy adults Total exposure was 43% higher. Evidence of a CYP3A interaction, not a 43% increase for every medicine using that pathway.
CYP2D6 and CYP3A test-drug ratios in 12 healthy adults Metabolism ratios fell by about 40% after 28 days. These are enzyme-activity measures, not prescription-drug blood levels.
Rosuvastatin, 10 mg; furosemide, 1 mg Neither showed a clear exposure change in the 16-person study. The result applies to those test doses and that preparation.
Digoxin, 0.5 mg test dose in 20 healthy adults Total 24-hour exposure did not change significantly; peak level rose about 14%. A mixed result for one dose, not an all-clear for digoxin use.

These are study comparisons, not dose-adjustment instructions. Give a pharmacist the exact goldenseal product and your full medicine list before combining them.

Metformin: the small test dose and the diabetes study differ

In a 2021 study of 16 healthy adults[6], researchers used NOW Foods goldenseal capsules described as root extract: 1 g three times daily for five days, followed by three further doses on the test day. With a 50 mg metformin test dose, total exposure was about 23% lower: a ratio of 0.77, with a 90% confidence interval of 0.71–0.83. Peak concentration was about 27% lower. These results explain the roughly 25% reduction often quoted in summaries; 50 mg is much less than a usual daily diabetes dose.

The 2025 follow-up[7] involved 22 adults with type 2 diabetes taking 500–2550 mg of metformin daily. It used Solaray whole-root capsules, with a single 3.3 g goldenseal exposure and a separate 28-day period of 1.1 g three times daily. The participants took their entire daily metformin dose together on sampling days.

Overall metformin exposure was about 7% lower: ratio 0.93, with a 90% confidence interval of 0.86–1.01—roughly 14% lower to 1% higher. The investigators classified that overall result within their predefined no-effect range. The lowest metformin-dose group showed a larger decrease; the highest showed little average change. Those small subgroups need confirmation.

This refines the earlier result rather than making 25% the expected reduction for every patient. The study changed both the metformin setting and the goldenseal product. If you take metformin, share the exact supplement and serving with the prescriber; do not change your medicine dose to compensate.

Effects on drug-processing enzymes

The same 16-person study used 2.5 mg of midazolam to test CYP3A activity, an enzyme pathway that processes many medicines. Midazolam exposure increased 43%, with a 90% confidence interval corresponding to a 35–53% increase. [6]

A separate 12-person study[8] used Wild Oats root extract at 900 mg three times daily for 28 days. Test-drug metabolism ratios for CYP3A and CYP2D6 fell by about 40%; the intervals were consistent with reduced activity. Those ratios measure enzyme activity, not a 40% change in every prescription drug’s blood level. The study did not show corresponding changes in its CYP1A2 or CYP2E1 tests.

Some medicines showed little or no change

In the 2021 medicine-interaction study, exposure to rosuvastatin, 10 mg, and furosemide, 1 mg, did not show a clear change. [6]

In a 20-person digoxin study[9], healthy adults took a goldenseal extract at 1,070 mg three times daily for 14 days. After a single 0.5 mg digoxin dose, total exposure over 24 hours did not change significantly, although the peak concentration rose about 14%.

The original indinavir study abstract[10] also reports no significant change in indinavir exposure in ten healthy volunteers after 1,140 mg goldenseal root twice daily for 14 days. Its product and full methods are less completely characterized here. The result applies to that experiment, not all medicines processed through CYP3A.

Have a pharmacist review the actual medicine list.

Drawbacks and side effects

Potential drawback When/who it affects Research evidence Practical implication
Medicine levels can change Users of affected medicines Human studies show both increases and decreases, alongside drug-specific null results The effect depends on the medicine and product.
Uncertain prolonged-use safety Regular supplement users Human studies are short; animal research raises additional concerns A brief course without symptoms does not establish long-term safety.
Harm to newborns Infants; pregnancy and breastfeeding NIH warns against use because of the berberine constituent Avoid goldenseal during pregnancy or breastfeeding; do not give it to infants.
Product substitution Some commercial products NCCIH reports unlisted or substituted ingredients Look for species authentication and batch testing.

Short studies offer limited reassurance. The 16-person probe study reported no severe adverse events, but three participants experienced abdominal cramping or bruising at the intravenous sampling site during at least one study period. In the digoxin study, two of twenty participants had raised liver enzymes after goldenseal, which returned to normal within seven days of stopping it. [6], [9]

Long-term animal findings deserve a separate mention. In National Toxicology Program experiments[11], groups of 50 rats or mice of each sex received root powder in feed for about two years. The program found liver-tumor evidence in male and female rats and in male mice, but not female mice under the tested conditions. These were animal exposures, including hundreds to thousands of milligrams per kilogram daily.

Persistent infection or digestive symptoms need their own assessment. The NIH pregnancy, breastfeeding and infant warning[1] remains relevant regardless of whether a product is described as traditional or natural.

The science behind goldenseal

Respiratory and digestive claims

The NIH assessment[1] finds insufficient evidence to determine whether goldenseal helps health conditions. The important distinction is between studying a plant’s biological activity and showing that a particular preparation shortens a cold, resolves diarrhea or improves another symptom in people.

For example, a 1999 immune experiment[12] tested goldenseal and echinacea root extracts in rats, following their antibody responses to an injected experimental antigen over six weeks. The goldenseal group had an increased early antibody response; echinacea increased a different type of antibody. This was not a human cold trial or a demonstration that combining the herbs works better.

Goldenseal also has laboratory antimicrobial research. A 2012 study[13] used a water–ethanol extract of the plant’s above-ground parts, described as a leaf extract. It altered signaling and toxin production in antibiotic-resistant Staphylococcus aureus bacteria and reduced injury to cultured skin cells. The experiment did not give root capsules to people with diarrhea or respiratory infections. It therefore cannot supply a treatment dose for those conditions.

Claims that hydrastine tightens inflamed mucosal tissue, that goldenseal clears specific intestinal pathogens, or that it provides a clinically proven boost to an echinacea cold remedy need matching human evidence.

Blood sugar: an exploratory signal with conflicting markers

The 2025 metformin study also measured glucose-control markers. HbA1c reflects average blood sugar over roughly three months, while fasting glucose measures the level at the time of the blood draw. Among 15 people with available HbA1c results, the average fell from 6.8% to 6.5% after the 28-day goldenseal period. Fasting glucose scarcely changed, from 141 to 140 mg/dL, and the other measured markers did not corroborate a glucose-lowering effect.

This was a small interaction study with the long goldenseal period always last, not a randomized trial designed to establish diabetes treatment. Changes in participants’ behavior during monitoring could have influenced the result. The HbA1c signal is a reason for further study, not a reason to substitute goldenseal for diabetes care. [7]

Does goldenseal help someone pass a drug test?

A controlled study’s original abstract[14] compared oral goldenseal and other products with water conditions. The authors attributed changes in urine test results to fluid dilution and found the herbal-product claims unfounded. It provides no basis for relying on goldenseal to defeat a drug test.

The bottom line

Goldenseal has a documented history as a root medicine, bitter digestive preparation and external remedy. Modern clinical evidence has not established dependable benefits for the colds or digestive conditions for which supplements are commonly marketed. Rat immune responses and laboratory leaf-extract results help explain research interest, but they do not validate a root capsule or an echinacea blend.

The clearer human finding is that specific goldenseal products can change medicine exposure. Some test medicines increased, metformin decreased in certain settings, and others showed little change. For anyone considering a product, the useful checks are its species, plant part, preparation and serving—and a review of the actual medicine list. Goldenseal is not interchangeable with isolated berberine, and a traditional dose is not an established effective or long-term-safe dose.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Email us directly